1n4m › Citations

Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.

Lee C, Chang JH, Lee HS, Cho Y
Genes Dev 16 3199-212 (2002)
Cited: 92 times
EuropePMC logo PMID: 12502741

Abstract

Repression of E2F transcription activity by the retinoblastoma (Rb) tumor suppressor through its interaction with the transactivation domain of the E2F transcription factor is one of the central features of G1/S arrest in the mammalian cell cycle. Deregulation of the Rb-E2F interaction results in hyperproliferation, lack of differentiation, and apoptosis, and can lead to cancer. The 2.2-A crystal structure of the Rb pocket complexed with an 18-residue transactivation-domain peptide of E2F-2 reveals that the boomerang-shaped peptide binds to the highly conserved interface between the A-box and the B-box of the Rb pocket in a bipartite manner. The N-terminal segment of the E2F-2 peptide in an extended beta-strand-like structure interacts with helices from the conserved groove at the A-B interface, whereas the C-terminal segment, which contains one 3(10) helix, binds to a groove mainly formed by A-box helices. The flexibility in the middle of the E2F-2 peptide is essential for the tight association of E2F to the Rb pocket. The binding of Rb to the E2F-2 peptide conceals several conserved residues that are crucial for transcription activation of E2F. We provide the structural basis for the Rb-mediated repression of E2F transcription activity without the requirement of histone-modifying enzymes.

Reviews - 1n4m mentioned but not cited (2)

  1. Molecular mechanisms underlying RB protein function. Dick FA, Rubin SM. Nat Rev Mol Cell Biol 14 297-306 (2013)
  2. Deciphering the retinoblastoma protein phosphorylation code. Rubin SM. Trends Biochem Sci 38 12-19 (2013)

Articles - 1n4m mentioned but not cited (11)

  1. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. Burke JR, Deshong AJ, Pelton JG, Rubin SM. J Biol Chem 285 16286-16293 (2010)
  2. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Lee C, Chang JH, Lee HS, Cho Y. Genes Dev 16 3199-3212 (2002)
  3. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Burke JR, Hura GL, Rubin SM. Genes Dev 26 1156-1166 (2012)
  4. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. Liu X, Marmorstein R. Genes Dev 21 2711-2716 (2007)
  5. Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example. Tuncbag N, Kar G, Gursoy A, Keskin O, Nussinov R. Mol Biosyst 5 1770-1778 (2009)
  6. Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain. Burke JR, Liban TJ, Restrepo T, Lee HW, Rubin SM. J Mol Biol 426 245-255 (2014)
  7. Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family. Liban TJ, Thwaites MJ, Dick FA, Rubin SM. J Mol Biol 428 3960-3971 (2016)
  8. Crystal structure of the unliganded retinoblastoma protein pocket domain. Balog ER, Burke JR, Hura GL, Rubin SM. Proteins 79 2010-2014 (2011)
  9. Folding of a cyclin box: linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor AB pocket domain. Chemes LB, Noval MG, Sánchez IE, de Prat-Gay G. J Biol Chem 288 18923-18938 (2013)
  10. Somatic alterations in brain tumors. Barnholtz-Sloan J, Sloan AE, Land S, Kupsky W, Monteiro AN. Oncol Rep 20 203-210 (2008)
  11. Structural basis for tunable affinity and specificity of LxCxE-dependent protein interactions with the retinoblastoma protein family. Putta S, Alvarez L, Lüdtke S, Sehr P, Müller GA, Fernandez SM, Tripathi S, Lewis J, Gibson TJ, Chemes LB, Rubin SM. Structure 30 1340-1353.e3 (2022)


Reviews citing this publication (19)

  1. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Burkhart DL, Sage J. Nat Rev Cancer 8 671-682 (2008)
  2. Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens. Cheng J, DeCaprio JA, Fluck MM, Schaffhausen BS. Semin Cancer Biol 19 218-228 (2009)
  3. RB1, development, and cancer. Chinnam M, Goodrich DW. Curr Top Dev Biol 94 129-169 (2011)
  4. How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40. DeCaprio JA. Virology 384 274-284 (2009)
  5. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements. Tonini T, D'Andrilli G, Fucito A, Gaspa L, Bagella L. J Cell Physiol 214 295-300 (2008)
  6. A survey of the year 2002 commercial optical biosensor literature. Rich RL, Myszka DG. J Mol Recognit 16 351-382 (2003)
  7. Rb/E2F: a two-edged sword in the melanocytic system. Halaban R. Cancer Metastasis Rev 24 339-356 (2005)
  8. Role of the retinoblastoma tumor suppressor protein in cellular differentiation. Nguyen DX, McCance DJ. J Cell Biochem 94 870-879 (2005)
  9. Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB. Hernández-Monge J, Rousset-Roman AB, Medina-Medina I, Olivares-Illana V. Genes Cancer 7 278-287 (2016)
  10. How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein. Goodrich DW. J Cell Physiol 197 169-180 (2003)
  11. Understanding the targeting of the RB family proteins by viral oncoproteins to defeat their oncogenic machinery. Bellacchio E, Paggi MG. J Cell Physiol 228 285-291 (2013)
  12. Eye cancer: unique insights into oncogenesis: the Cogan Lecture. Harbour JW. Invest Ophthalmol Vis Sci 47 1736-1745 (2006)
  13. Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation. Guzman F, Fazeli Y, Khuu M, Salcido K, Singh S, Benavente CA. Cancers (Basel) 12 E2807 (2020)
  14. Post-translational modifications on the retinoblastoma protein. Zhou L, Ng DS, Yam JC, Chen LJ, Tham CC, Pang CP, Chu WK. J Biomed Sci 29 33 (2022)
  15. The Function of SUMOylation and Its Role in the Development of Cancer Cells under Stress Conditions: A Systematic Review. Zhao Q, Ma Y, Li Z, Zhang K, Zheng M, Zhang S. Stem Cells Int 2020 8835714 (2020)
  16. Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies. Janostiak R, Torres-Sanchez A, Posas F, de Nadal E. Cancers (Basel) 14 1265 (2022)
  17. Retinoblastoma Protein Paralogs and Tumor Suppression. Flores M, Goodrich DW. Front Genet 13 818719 (2022)
  18. The Four Homeostasis Knights: In Balance upon Post-Translational Modifications. Pieroni S, Castelli M, Piobbico D, Ferracchiato S, Scopetti D, Di-Iacovo N, Della-Fazia MA, Servillo G. Int J Mol Sci 23 14480 (2022)
  19. Retinoblastoma: present scenario and future challenges. Byroju VV, Nadukkandy AS, Cordani M, Kumar LD. Cell Commun Signal 21 226 (2023)

Articles citing this publication (60)

  1. Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Lewis PW, Beall EL, Fleischer TC, Georlette D, Link AJ, Botchan MR. Genes Dev 18 2929-2940 (2004)
  2. Systematic discovery of new recognition peptides mediating protein interaction networks. Neduva V, Linding R, Su-Angrand I, Stark A, de Masi F, Gibson TJ, Lewis J, Serrano L, Russell RB, Russell RB. PLoS Biol 3 e405 (2005)
  3. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Tyagi S, Chabes AL, Wysocka J, Herr W. Mol Cell 27 107-119 (2007)
  4. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Rubin SM, Gall AL, Zheng N, Pavletich NP. Cell 123 1093-1106 (2005)
  5. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Ferreon JC, Martinez-Yamout MA, Dyson HJ, Wright PE. Proc Natl Acad Sci U S A 106 13260-13265 (2009)
  6. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Dick FA, Dyson N. Mol Cell 12 639-649 (2003)
  7. An in vitro microfluidic approach to generating protein-interaction networks. Gerber D, Maerkl SJ, Quake SR. Nat Methods 6 71-74 (2009)
  8. Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. Inoue Y, Kitagawa M, Taya Y. EMBO J 26 2083-2093 (2007)
  9. Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection. Ferrari R, Gou D, Jawdekar G, Johnson SA, Nava M, Su T, Yousef AF, Zemke NR, Pellegrini M, Kurdistani SK, Berk AJ. Cell Host Microbe 16 663-676 (2014)
  10. Structural mechanisms of DREAM complex assembly and regulation. Guiley KZ, Liban TJ, Felthousen JG, Ramanan P, Litovchick L, Rubin SM. Genes Dev 29 961-974 (2015)
  11. Recruitment of Cln3 cyclin to promoters controls cell cycle entry via histone deacetylase and other targets. Wang H, Carey LB, Cai Y, Wijnen H, Futcher B. PLoS Biol 7 e1000189 (2009)
  12. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Ledl A, Schmidt D, Müller S. Oncogene 24 3810-3818 (2005)
  13. Structure-function analysis of the retinoblastoma tumor suppressor protein - is the whole a sum of its parts? Dick FA. Cell Div 2 26 (2007)
  14. Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous end-joining. Cook R, Zoumpoulidou G, Luczynski MT, Rieger S, Moquet J, Spanswick VJ, Hartley JA, Rothkamm K, Huang PH, Mittnacht S. Cell Rep 10 2006-2018 (2015)
  15. EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. Tallack MR, Keys JR, Humbert PO, Perkins AC. J Biol Chem 284 20966-20974 (2009)
  16. Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein. Mishra S, Melino G, Murphy LJ. J Biol Chem 282 18108-18115 (2007)
  17. Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture. Hassler M, Singh S, Yue WW, Luczynski M, Lakbir R, Sanchez-Sanchez F, Bader T, Pearl LH, Mittnacht S. Mol Cell 28 371-385 (2007)
  18. Increased autophagy reduces endoplasmic reticulum stress after neonatal hypoxia-ischemia: role of protein synthesis and autophagic pathways. Carloni S, Albertini MC, Galluzzi L, Buonocore G, Proietti F, Balduini W. Exp Neurol 255 103-112 (2014)
  19. Transcriptional activation of histone genes requires NPAT-dependent recruitment of TRRAP-Tip60 complex to histone promoters during the G1/S phase transition. DeRan M, Pulvino M, Greene E, Su C, Zhao J. Mol Cell Biol 28 435-447 (2008)
  20. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome. Nakamura Y, Nakano K, Umehara T, Kimura M, Hayashizaki Y, Tanaka A, Horikoshi M, Padmanabhan B, Yokoyama S. Structure 15 179-189 (2007)
  21. The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein. Cecchini MJ, Dick FA. Biochem J 434 297-308 (2011)
  22. p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis. Delston RB, Matatall KA, Sun Y, Onken MD, Harbour JW. Oncogene 30 588-599 (2011)
  23. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7. Chemes LB, Sánchez IE, Smal C, de Prat-Gay G. FEBS J 277 973-988 (2010)
  24. Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target. Chemes LB, Sánchez IE, de Prat-Gay G. J Mol Biol 412 267-284 (2011)
  25. Historical Article Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture. Grossniklaus HE. Am J Ophthalmol 158 875-891 (2014)
  26. N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding. Fladvad M, Zhou K, Moshref A, Pursglove S, Säfsten P, Sunnerhagen M. J Mol Biol 346 175-189 (2005)
  27. Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma. Imai MA, Oda Y, Oda M, Nakanishi I, Kawahara E. J Cancer Res Clin Oncol 130 320-326 (2004)
  28. The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex. Zhou M, Yang Z, Wang D, Chen P, Zhang Y. J Exp Clin Cancer Res 40 48 (2021)
  29. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97. Iwahori S, Hakki M, Chou S, Kalejta RF. J Biol Chem 290 19666-19680 (2015)
  30. RB regulates pancreas development by stabilizing Pdx1. Kim YC, Kim SY, Mellado-Gil JM, Yadav H, Neidermyer W, Kamaraju AK, Rane SG. EMBO J 30 1563-1576 (2011)
  31. MDMX exerts its oncogenic activity via suppression of retinoblastoma protein. Zhang H, Hu L, Qiu W, Deng T, Zhang Y, Bergholz J, Xiao ZX. Oncogene 34 5560-5569 (2015)
  32. PRMT4-mediated arginine methylation negatively regulates retinoblastoma tumor suppressor protein and promotes E2F-1 dissociation. Kim KY, Wang DH, Campbell M, Huerta SB, Shevchenko B, Izumiya C, Izumiya Y. Mol Cell Biol 35 238-248 (2015)
  33. Short linear motif core and flanking regions modulate retinoblastoma protein binding affinity and specificity. Palopoli N, González Foutel NS, Gibson TJ, Chemes LB. Protein Eng Des Sel 31 69-77 (2018)
  34. Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort. Singh J, Mishra A, Pandian AJ, Mallipatna AC, Khetan V, Sripriya S, Kapoor S, Agarwal S, Sankaran S, Katragadda S, Veeramachaneni V, Hariharan R, Subramanian K, Mannan AU. Mol Vis 22 1036-1047 (2016)
  35. XYLEM NAC DOMAIN1, an angiosperm NAC transcription factor, inhibits xylem differentiation through conserved motifs that interact with RETINOBLASTOMA-RELATED. Zhao C, Lasses T, Bako L, Kong D, Zhao B, Chanda B, Bombarely A, Cruz-Ramírez A, Scheres B, Brunner AM, Beers EP. New Phytol 216 76-89 (2017)
  36. Paradoxical instability-activity relationship defines a novel regulatory pathway for retinoblastoma proteins. Acharya P, Raj N, Buckley MS, Zhang L, Duperon S, Williams G, Henry RW, Arnosti DN. Mol Biol Cell 21 3890-3901 (2010)
  37. Conformational dissection of a viral intrinsically disordered domain involved in cellular transformation. Noval MG, Gallo M, Perrone S, Salvay AG, Chemes LB, de Prat-Gay G. PLoS One 8 e72760 (2013)
  38. Structural insights into the mechanism of phosphoregulation of the retinoblastoma protein. Lamber EP, Beuron F, Morris EP, Svergun DI, Mittnacht S. PLoS One 8 e58463 (2013)
  39. A comparative study of Whi5 and retinoblastoma proteins: from sequence and structure analysis to intracellular networks. Hasan MM, Brocca S, Sacco E, Spinelli M, Papaleo E, Lambrughi M, Alberghina L, Vanoni M. Front Physiol 4 315 (2013)
  40. Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration. Roesley SN, Suryadinata R, Morrish E, Tan AR, Issa SM, Oakhill JS, Bernard O, Welch DR, Šarčević B. Cell Cycle 15 137-151 (2016)
  41. Evolution of linear motifs within the papillomavirus E7 oncoprotein. Chemes LB, Glavina J, Faivovich J, de Prat-Gay G, Sánchez IE. J Mol Biol 422 336-346 (2012)
  42. The Interaction Mode of the Acidic Region of the Cell Cycle Transcription Factor DP1 with TFIIH. Okuda M, Araki K, Ohtani K, Nishimura Y. J Mol Biol 428 4993-5006 (2016)
  43. Phosphorylation puts the pRb tumor suppressor into shape. Heilmann AM, Dyson NJ. Genes Dev 26 1128-1130 (2012)
  44. Reduction of apoptosis in Rb-deficient embryos via Abl knockout. Borges HL, Hunton IC, Wang JY. Oncogene 26 3868-3877 (2007)
  45. 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer. Mayrhofer M, Kultima HG, Birgisson H, Sundström M, Mathot L, Edlund K, Viklund B, Sjöblom T, Botling J, Micke P, Påhlman L, Glimelius B, Isaksson A. BMC Cancer 14 872 (2014)
  46. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis. Wei T, Grace M, Uberoi A, Romero-Masters JC, Lee D, Lambert PF, Munger K. mBio 12 e0227721 (2021)
  47. Unraveling the mechanism of a potent transcriptional activator. Lu Z, Rowe SP, Brennan BB, Davis SE, Metzler RE, Nau JJ, Majmudar CY, Mapp AK, Ansari AZ. J Biol Chem 280 29689-29698 (2005)
  48. Rbf1 degron dysfunction enhances cellular DNA replication. Raj N, Zhang L, Wei Y, Arnosti DN, Henry RW. Cell Cycle 11 3731-3738 (2012)
  49. Structural and functional characterization of the acidic region from the RIZ tumor suppressor. Sun Y, Stine JM, Atwater DZ, Sharmin A, Ross JB, Briknarová K. Biochemistry 54 1390-1400 (2015)
  50. Dynamic site-specific recruitment of RBP2 by pocket protein p130 modulates H3K4 methylation on E2F-responsive promoters. Zargar ZU, Kimidi MR, Tyagi S. Nucleic Acids Res 46 174-188 (2018)
  51. Retinoblastoma family proteins: New players in DNA repair by non-homologous end-joining. Huang PH, Cook R, Zoumpoulidou G, Luczynski MT, Mittnacht S. Mol Cell Oncol 3 e1053596 (2016)
  52. Molecular dynamics simulations of retinoblastoma protein. Ramakrishnan C, Subramanian V, Balamurugan K, Velmurugan D. J Biomol Struct Dyn 31 1277-1292 (2013)
  53. RB1 loss triggers dependence on ESRRG in retinoblastoma. Field MG, Kuznetsoff JN, Zhang MG, Dollar JJ, Durante MA, Sayegh Y, Decatur CL, Kurtenbach S, Pelaez D, Harbour JW. Sci Adv 8 eabm8466 (2022)
  54. A Mathematical Model of Cell Cycle Dysregulation Due to Human Papillomavirus Infection. Miller AK, Munger K, Adler FR. Bull Math Biol 79 1564-1585 (2017)
  55. Control of mitotic chromosome condensation by the fission yeast transcription factor Zas1. Schiklenk C, Petrova B, Kschonsak M, Hassler M, Klein C, Gibson TJ, Haering CH. J Cell Biol 217 2383-2401 (2018)
  56. Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma. Hülsenbeck I, Frank M, Biewald E, Kanber D, Lohmann DR, Ketteler P. Cancers (Basel) 13 1605 (2021)
  57. miR-365 Suppresses Cholangiocarcinoma Cell Proliferation and Induces Apoptosis by Targeting E2F2. Chen L, Huang X, Chen X. Oncol Res 26 1375-1382 (2018)
  58. Clefts, grooves, and (small) pockets: the structure of the retinoblastoma tumor suppressor in complex with its cellular target E2F unveiled. Munger K. Proc Natl Acad Sci U S A 100 2165-2167 (2003)
  59. Multiple molecular interactions redundantly contribute to RB-mediated cell cycle control. Thwaites MJ, Cecchini MJ, Talluri S, Passos DT, Carnevale J, Dick FA. Cell Div 12 3 (2017)
  60. A transcription factor primes the condensin pump. Gerton JL. J Cell Biol 217 2233-2234 (2018)


Quick links